158 related articles for article (PubMed ID: 9920814)
1. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.
Satoh H; Tsukamoto K; Hashimoto Y; Hashimoto N; Togo M; Hara M; Maekawa H; Isoo N; Kimura S; Watanabe T
Biochem Biophys Res Commun; 1999 Jan; 254(3):757-63. PubMed ID: 9920814
[TBL] [Abstract][Full Text] [Related]
2. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
Chen NG; Han X
Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
[TBL] [Abstract][Full Text] [Related]
3. PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells.
Chiba Y; Ogita T; Ando K; Fujita T
Biochem Biophys Res Commun; 2001 Aug; 286(3):541-6. PubMed ID: 11511093
[TBL] [Abstract][Full Text] [Related]
4. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.
Kato K; Satoh H; Endo Y; Yamada D; Midorikawa S; Sato W; Mizuno K; Fujita T; Tsukamoto K; Watanabe T
Biochem Biophys Res Commun; 1999 May; 258(2):431-5. PubMed ID: 10329404
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone induces expression of PPARgamma in liver.
Davies GF; Khandelwal RL; Roesler WJ
Mol Cell Biol Res Commun; 1999; 2(3):202-8. PubMed ID: 10662598
[TBL] [Abstract][Full Text] [Related]
9. Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes.
Barthel A; Krüger KD; Roth RA; Joost HG
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):290-5. PubMed ID: 11919653
[TBL] [Abstract][Full Text] [Related]
10. GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells.
Abe M; Hasegawa K; Wada H; Morimoto T; Yanazume T; Kawamura T; Hirai M; Furukawa Y; Kita T
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):404-10. PubMed ID: 12615657
[TBL] [Abstract][Full Text] [Related]
11. Activators of PPARgamma antagonize protection of cardiac myocytes by endothelin-1.
Ehara N; Hasegawa K; Ono K; Kawamura T; Iwai-Kanai E; Morimoto T; Akao M; Adachi S; Kita T
Biochem Biophys Res Commun; 2004 Aug; 321(2):345-9. PubMed ID: 15358182
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
[TBL] [Abstract][Full Text] [Related]
13. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells.
Goya K; Sumitani S; Otsuki M; Xu X; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S
J Diabetes Complications; 2006; 20(5):336-42. PubMed ID: 16949522
[TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
15. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.
Asano M; Nakajima T; Iwasawa K; Morita T; Nakamura F; Imuta H; Chisaki K; Yamada N; Omata M; Okuda Y
Br J Pharmacol; 1999 Oct; 128(3):673-83. PubMed ID: 10516648
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
[TBL] [Abstract][Full Text] [Related]
18. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells.
Schoppee PD; Garmey JC; Veldhuis JD
Biol Reprod; 2002 Jan; 66(1):190-8. PubMed ID: 11751282
[TBL] [Abstract][Full Text] [Related]
19. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.
Yamakawa K; Hosoi M; Koyama H; Tanaka S; Fukumoto S; Morii H; Nishizawa Y
Biochem Biophys Res Commun; 2000 May; 271(3):571-4. PubMed ID: 10814503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]